Features - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

26 to 37 of 37 results

FT Pharma 2013: NICE chair David Haslam says “I want as many yeses as possible”

FT Pharma 2013: NICE chair David Haslam says “I want as many yeses as possible”

04-12-2013

The chair of the UK’s regulatory body the National Institute for Health and Care Excellence shared…

InterviewsPharmaceuticalRegulationUK

FT Pharma 2013: Bayer chairman Marijn Dekkers says “patients don’t appreciate us”

FT Pharma 2013: Bayer chairman Marijn Dekkers says “patients don’t appreciate us”

03-12-2013

Most patients don’t appreciate the pharma companies that save their lives, Bayer chairman Marijn Dekkers…

BayerHealthcareInterviewsPharmaceuticalPoliticsUSA

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

03-12-2013

The UK’s ‘Golden Triangle’ of biotech innovation can compete on the world stage, AstraZeneca (LSE:…

AstraZenecaBoardroomBrilintaInterviewsPharmaceuticalUK

Interview: Clinigen’s CEO Peter George on the company’s record growth

Interview: Clinigen’s CEO Peter George on the company’s record growth

15-11-2013

If there is one pharma company bucking the trend of shaky financial results it is the Clinigen Group.

BoardroomClinigen GroupFoscavirInterviewsOncologyPharmaceuticalRare diseasesUK

EXPERT VIEW: Talent acquisition at the heart of M&A

EXPERT VIEW: Talent acquisition at the heart of M&A

22-10-2013

Mergers and acquisitions are common – 111 M&As took place in the UK in the second quarter of 2013 alone…

BoardroomInterviewsMergers & AcquisitionsPharmaceutical

BIA UK BioScience Forum: The benefits of the European Unitary Patent

BIA UK BioScience Forum: The benefits of the European Unitary Patent

14-10-2013

Updates on Intellectual Property developments in Europe were heard by delegates at the BIA UK BioScience…

EuropeInterviewsPatentsPharmaceutical

IN FOCUS: A post-ERS look at Verona Pharma’s respiratory pipeline

IN FOCUS: A post-ERS look at Verona Pharma’s respiratory pipeline

20-09-2013

Fresh from their trip to the European Respiratory Society annual congress in Barcelona, Verona Pharma’s…

EuropeInterviewsPharmaceuticalResearchRespiratory and Pulmonary

EXPERT VIEW: AstraZeneca warns of

EXPERT VIEW: AstraZeneca warns of "significant risk to health" from antimicrobial resistance

13-09-2013

One of the UK's leading pharma companies has expressed its support for the Department of Health's five…

AstraZenecaEuropeHealthcareInterviewsPharmaceutical

EXPERT VIEW: What does the future hold for clinical trials data and pharmacovigilance in Europe?

EXPERT VIEW: What does the future hold for clinical trials data and pharmacovigilance in Europe?

12-09-2013

Europe is leading the way when it comes to transparency in clinical trials data, says regulatory lawyer…

EuropeInterviewsPharmaceutical

EXPERT VIEW: Patent attorney Gareth Williams speaks about the potential issues facing the pharmaceutical industry

EXPERT VIEW: Patent attorney Gareth Williams speaks about the potential issues facing the pharmaceutical industry

18-07-2013

As patent expiration becomes an increasing hurdle for pharma companies worldwide, The Pharma Letter spoke…

InterviewsPharmaceutical

26 to 37 of 37 results

Back to top